Published in Arthritis Care Res (Hoboken) on July 01, 2014
Access to an optimal treatment. Current situation. Clin Rheumatol (2015) 0.80
Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study. Rheumatol Ther (2015) 0.77
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 12.07
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum (2008) 9.94
A glossary for health inequalities. J Epidemiol Community Health (2002) 4.42
Benefit design and specialty drug use. Health Aff (Millwood) (2006) 3.44
Monitoring equity in health and healthcare: a conceptual framework. J Health Popul Nutr (2003) 2.83
Access to specialty care and medical services in community health centers. Health Aff (Millwood) (2007) 2.63
Dropping the baton: specialty referrals in the United States. Milbank Q (2011) 2.34
Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum (2005) 2.20
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18
Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. JAMA (2011) 2.17
Inequities in access to biologic and synthetic DMARDs across 46 European countries. Ann Rheum Dis (2013) 1.90
Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis. Ann Rheum Dis (2005) 1.77
Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort. J Rheumatol (2012) 1.60
Decision tool to improve the quality of care in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 1.46
Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort. J Rheumatol (2011) 1.43
Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 1.35
Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey. Arthritis Care Res (Hoboken) (2012) 1.16
Health care utilization and outcomes among persons with rheumatoid arthritis in fee-for-service and prepaid group practice settings. JAMA (1996) 1.11
A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practices. N Engl J Med (1985) 1.02
Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission. Ann Rheum Dis (2010) 0.98
Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients. Arthritis Care Res (Hoboken) (2013) 0.96
Efficacy of biologicals in the treatment of rheumatoid arthritis. a meta-analysis. Pharmacology (2008) 0.93
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum (2008) 19.80
Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev (2004) 15.57
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84
Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44
Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol (2004) 7.45
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum (2003) 6.68
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage. Ann Intern Med (2009) 6.33
Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med (2005) 6.29
Surgery versus physical therapy for a meniscal tear and osteoarthritis. N Engl J Med (2013) 6.08
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol (2008) 5.61
Physician performance and racial disparities in diabetes mellitus care. Arch Intern Med (2008) 5.04
Development of the QuickDASH: comparison of three item-reduction approaches. J Bone Joint Surg Am (2005) 4.90
The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One (2010) 4.75
Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med (2004) 4.68
Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol (2003) 4.50
Effect of cost sharing on screening mammography in Medicare health plans. N Engl J Med (2008) 4.48
Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am (2003) 4.38
The importance of patient expectations in predicting functional outcomes after total joint arthroplasty. J Rheumatol (2002) 4.16
Cultural competency training and performance reports to improve diabetes care for black patients: a cluster randomized, controlled trial. Ann Intern Med (2010) 4.01
Implementing open-access scheduling of visits in primary care practices: a cautionary tale. Ann Intern Med (2008) 4.01
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS (2010) 3.93
Impact of Medicare coverage on basic clinical services for previously uninsured adults. JAMA (2003) 3.93
Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med (2009) 3.84
Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78
Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 3.75
Predicting the outcome of total knee arthroplasty. J Bone Joint Surg Am (2004) 3.70
Altitude and all-cause mortality in incident dialysis patients. JAMA (2009) 3.62
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA (2011) 3.58
Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57
Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54
Use of health services by previously uninsured Medicare beneficiaries. N Engl J Med (2007) 3.41
Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am (2003) 3.33
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum (2002) 3.29
Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med (2011) 3.27
Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst (2003) 3.21
Group exercise, education, and combination self-management in women with fibromyalgia: a randomized trial. Arch Intern Med (2007) 3.20
Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med (2011) 3.11
Incentives for drug development--the curious case of colchicine. N Engl J Med (2010) 3.06
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med (2003) 3.01
The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Joint Surg Am (2012) 2.98
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93
Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91
Development of classification and response criteria for rheumatic diseases. Arthritis Rheum (2006) 2.88
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum (2010) 2.88
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77
Trends in epidemiology of knee arthroplasty in the United States, 1990-2000. Arthritis Rheum (2005) 2.76
Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care (2005) 2.75
Revising expectations from rapid HIV tests in the emergency department. Ann Intern Med (2008) 2.74
Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer (2006) 2.73
Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol (2003) 2.72
Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care (2003) 2.69
Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am (2005) 2.67
Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med (2009) 2.65
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol (2011) 2.61
Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med (2004) 2.52
Veteran's affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol (2006) 2.51
Relationship between quality of care and racial disparities in Medicare health plans. JAMA (2006) 2.49
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
Medicare spending for previously uninsured adults. Ann Intern Med (2009) 2.47
Perceived discrimination and use of preventive health services. J Gen Intern Med (2006) 2.45
Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42
Biologic discontinuation studies: a systematic review of methods. Ann Rheum Dis (2013) 2.42
Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis Rheum (2007) 2.41
Health of previously uninsured adults after acquiring Medicare coverage. JAMA (2007) 2.41
Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med (2008) 2.40
Factors affecting influential discussions among physicians: a social network analysis of a primary care practice. J Gen Intern Med (2007) 2.39
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis (2010) 2.39
Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology (2005) 2.38
Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.37
Effect of quality improvement on racial disparities in diabetes care. Arch Intern Med (2006) 2.36
Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med (2011) 2.35
Health insurance coverage and mortality among the near-elderly. Health Aff (Millwood) (2004) 2.35
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31
Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum (2003) 2.30
Rotator cuff disorders: recognition and management among patients with shoulder pain. Arthritis Rheum (2004) 2.28
Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Med Care (2005) 2.28
Psychosocial stress and change in weight among US adults. Am J Epidemiol (2009) 2.26
Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care (2005) 2.25
Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther (2011) 2.24
Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol (2006) 2.24
Evidence of sample use among new users of statins: implications for pharmacoepidemiology. Med Care (2014) 2.22
Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care (2013) 2.22
Unintended consequences of eliminating medicare payments for consultations. JAMA Intern Med (2013) 2.21
Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol (2011) 2.20